Bank Of Montreal Tg Therapeutics, Inc. Transaction History

Bank Of Montreal

$192 Billion
Q1 2025

A detailed history of Bank Of Montreal transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 524,475 shares of TGTX stock, worth $19.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

524,475

Previous 20,016 2520.28%

Holding current value

$19.6 Million

Previous $602,000 3335.22%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$27.67 - $42.99 $14 Million - $21.7 Million	504,459 Added 2520.28%	524,475 $20.7 Million
Q4 2024 Feb 13, 2025	BUY	$21.31 - $35.09 $28,917 - $47,617	1,357 Added 7.27%	20,016 $602,000
Q3 2024 Nov 13, 2024	BUY	$17.21 - $25.28 $321,121 - $471,699	18,659 New	18,659 $436,000
Q1 2024 May 13, 2024	BUY	$13.02 - $21.3 $633,748 - $1.04 Million	48,675 New	48,675 $740,000
Q2 2023 Aug 02, 2023	SELL	$15.48 - $35.0 $1.76 Million - $3.99 Million	-113,898 Reduced 47.1%	127,933 $3.18 Million
Q1 2023 Jun 13, 2024	BUY	$10.23 - $19.34 $691,077 - $1.31 Million	67,554 Added 138.79%	116,229 $1.75 Million
Q4 2022 Feb 01, 2023	BUY	$5.01 - $11.83 $776,444 - $1.83 Million	154,979 Added 178.44%	241,831 $2.86 Million
Q3 2022 Nov 10, 2022	BUY	$4.57 - $8.4 $15,542 - $28,568	3,401 Added 4.08%	86,852 $546,000
Q2 2022 Aug 11, 2022	BUY	$3.74 - $10.66 $721 - $2,057	193 Added 0.23%	83,451 $366,000
Q1 2022 May 12, 2022	BUY	$7.81 - $20.45 $42,806 - $112,086	5,481 Added 7.05%	83,258 $820,000
Q4 2021 Feb 11, 2022	SELL	$15.2 - $35.51 $12,144 - $28,372	-799 Reduced 1.02%	77,777 $1.53 Million
Q3 2021 Nov 12, 2021	SELL	$21.78 - $40.45 $9,408 - $17,474	-432 Reduced 0.55%	78,576 $2.65 Million
Q2 2021 Aug 12, 2021	BUY	$32.5 - $48.96 $2.57 Million - $3.87 Million	79,008 New	79,008 $3.12 Million

Others Institutions Holding TGTX

# of Institutions

416

Shares Held

88.1M

Call Options Held

2.34M

Put Options Held

1.94M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.42B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account